Zydus Cadila aims to complete the trial of COVID-19 vaccine by March 2021


Ahmedabad-based Zydus Cadila plans to complete late-stage trials for its coronavirus vaccine candidate, known as ZyCov-D, by February or March 2021, Chairman Pankaj Patel has said. Early-stage Phase 1 and 2 clinical trials are likely to be concluded in the next three months, he added. The company also plans to make Gilead's remdesivir, used in treating COVID-19 patients, after approvals.

Subscribe to Our Newsletter

  • White Facebook Icon
  • Instagram

© 2020 by Hectique. All rights reserved.